Skip to main content
NovaBay Pharmaceuticals, Inc. logo

NovaBay Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · NBY ISIN · US66987P2011 LEI · 549300D5U7PQPNEX8Q38 US Manufacturing
Filings indexed 1,026 across all filing types
Latest filing 2025-05-15 Interim / Quarterly Rep…
Country US United States of America
Listing US NBY

About NovaBay Pharmaceuticals, Inc.

https://novabay.com/

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company that develops and commercializes scientifically-created and clinically-proven products for the eyecare, skincare, and wound care markets. The company's core technology is a proprietary, stable formulation of hypochlorous acid. Its leading product is Avenova®, an antimicrobial lid and lash solution available over-the-counter for eye hygiene. In the wound care sector, NovaBay manufactures and sells products under the NeutroPhase® and PhaseOne® brands, which utilize its hypochlorous acid technology to aid in cleansing and debridement. The company focuses on providing accessible, problem-solving solutions for improved well-being.

Recent filings

Filing Released Lang Actions
FORM 10-Q
Interim / Quarterly Report Q1 2025
2025-05-15 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-05-15 English
FORM 8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The content focuses on the submission of matters to a vote of security holders at a special meeting, specifically the approval of the liquidation and dissolution of the company and the voting results. This corresponds to an official announcement of voting results from a shareholder meeting. The document is not a full annual or quarterly report, nor is it a proxy solicitation or management discussion. It clearly reports the voting outcomes, which fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length and content confirm it is not merely an announcement of a report but the actual voting results report. Therefore, the correct classification is DVA with high confidence.
2025-04-22 English
Director's Dealing 2025
Director's Dealing
2025-04-15 English
Director's Dealing 2025
Director's Dealing
2025-04-15 English
Director's Dealing 2025
Director's Dealing
2025-04-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.